tiprankstipranks

GB:MRN3 ETF Technical Analysis

Compare

Summary of all the Indicators

Summary
Buy
10Bullish
5Neutral
7Bearish
Oscillators
Buy
4Bullish
5Neutral
1Bearish
Moving Averages
Neutral
6Bullish
0Neutral
6Bearish
Leverage Shares 3x Long Moderna (MRNA) ETP Securities’s (MRN3) Moving Averages Convergence Divergence (MACD) indicator is -8.35, suggesting Leverage Shares 3x Long Moderna (MRNA) ETP Securities is a Sell.
Leverage Shares 3x Long Moderna (MRNA) ETP Securities’s (MRN3) 20-Day exponential moving average is 33.84, making it a Buy.
Leverage Shares 3x Long Moderna (MRNA) ETP Securities’s (MRN3) 50-Day exponential moving average is 90.39, making it a Sell.

Leverage Shares 3x Long Moderna (MRNA) ETP Securities (MRN3) Pivot Points

Mar 10, 2025, 05:15 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
20.09
22.52
26.70
29.13
33.31
35.74
39.92
Fibonacci
22.52
25.05
26.60
29.13
31.66
33.21
35.74

Leverage Shares 3x Long Moderna (MRNA) ETP Securities (MRN3) Moving Averages

Mar 10, 2025, 05:15 AM
Period
Simple
Exponential
MA5
27.57Buy
30.26Buy
MA10
28.42Buy
29.67Buy
MA20
29.78Buy
33.84Buy
MA50
58.35Sell
90.39Sell
MA100
134.99Sell
598.04Sell
MA200
2,721.44Sell
2,935.28Sell
Leverage Shares 3x Long Moderna (MRNA) ETP Securities’s (MRN3) 10-Day exponential moving average is 29.67, making it a Buy.
Leverage Shares 3x Long Moderna (MRNA) ETP Securities’s (MRN3) 100-Day exponential moving average is 598.04, making it a Sell.
Leverage Shares 3x Long Moderna (MRNA) ETP Securities’s (MRN3) 50-day simple moving average is 58.35, creating a Sell signal.
Leverage Shares 3x Long Moderna (MRNA) ETP Securities’s (MRN3) 100-day simple moving average is 134.99, creating a Sell signal.
Leverage Shares 3x Long Moderna (MRNA) ETP Securities’s (MRN3) 200-day simple moving average is 2721.44, creating a Sell signal.

Leverage Shares 3x Long Moderna (MRNA) ETP Securities (MRN3) Technical Analysis

Mar 10, 2025, 05:15 AM
Name
Value
Action
RSI (14)
47.93
Neutral
STOCH (9,6)
60.67
Neutral
STOCHRSI (14)
48.41
Neutral
MACD (12,26)
-8.35
Sell
ADX (14)
9.62
Buy
Williams %R
-24.83
Buy
CCI (14)
89.68
Neutral
ATR (14)
8.69
-
Ultimate Oscillator
52.19
Neutral
ROC
18.24
Buy
Leverage Shares 3x Long Moderna (MRNA) ETP Securities’s (MRN3) Relative Strength Index (RSI) is 47.93, creating a Neutral signal.
Leverage Shares 3x Long Moderna (MRNA) ETP Securities’s (MRN3) Trend Strength Indicator (ADX) is 9.62, creating a Buy signal.
Leverage Shares 3x Long Moderna (MRNA) ETP Securities’s (MRN3) Commodity Channel Index (CCI) is 89.68, creating a Neutral signal.
Leverage Shares 3x Long Moderna (MRNA) ETP Securities’s (MRN3) Price Rate of Change (ROC) is 18.24, creating a Buy signal.

FAQ

Is MRN3 a Buy, Hold, or Sell?
Based on MRN3’s technical indicators, MRN3 is a Buy.
    What is MRN3’s RSI (14)?
    MRN3’s RSI (14) is 47.93, which suggests MRN3 is a Neutral.
      What is MRN3’s MACD?
      MRN3’s MACD is -8.35, which suggests MRN3 is a Sell.
        What is MRN3’s 5-day moving average?
        MRN3’s 5-day moving average is 27.57, which suggests MRN3 is a Buy.
          What is MRN3’s 20-day moving average?
          MRN3 20-day moving average is 29.78, which suggests MRN3 is a Buy.
            What is MRN3’s 50-day moving average?
            MRN3’s 50-day moving average is 58.35, which suggests MRN3 is a Sell.
              What is MRN3’s 200-day moving average?
              MRN3’s 200-day moving average is 2721.44, which suggests MRN3 is a Sell.
                What is MRN3’s Williams % R (14)?
                MRN3’s Williams % R (14) is -24.83, which suggests MRN3 is a Buy.
                  What is MRN3’s CCI (14)?
                  MRN3’s CCI (14) is 89.68, which suggests MRN3 is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis